Back to Investors
GC

Glenview Capital

Venture Capital

Portfolio

1

companies


Portfolio companies

Quanta Dialysis Technologies

Quanta Dialysis Technologies

Quanta Dialysis Technologies provides compact dialysis systems for clinical and home use.


Team

LH

Lee Hathaway

Partner and Co-Head of Healthcare

LM

Lloyd Mandell

Managing Director


Recent investments

Series D+
£47.4M

Novo Holdings, Glenview Capital and b2venture led the Series E round, which will fund commercial expansion in the US.

"Our commitment to delivering innovative solutions for acute care has never been stronger. This financing round provides the resources to solidify Quanta as the best-in-class solution across the care continuum, to significantly expand our commercial operations, while continuing to introduce enhancements that will strengthen our long-term competitive position."
— Alejandro Galindo, Chief Executive Officer
Series D+
£175M

The financing round was led by Glenview Capital and co-led by Novo Holdings.

"Everybody knows that dialysis care must improve. For this to happen, providers and physicians need products that allow greater flexibility to bring dialysis directly to the patient, while simplifying complexity and reducing the overall cost of care. Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care. The funding we are announcing today will allow us to accelerate our emergence as a significant force in this market."
— John Milad, CEO